PSIX vs AME vs DOV Stock Comparison

Power Solutions International, Ametek and Dover Prices as of Oct 29, 2026 Peers: Industry group
1 more company in this comparison (MMM) Create a free account to keep reading and compare up to 10 companies.
AME Ametek Inc/
$251.75 +0.4% 1M +36.7% 1Y
Market cap
$55.52B
P/E
35.2x
Revenue (TTM)
$7.86B
Div. yield
0.01%
Industrial Machinery Industrials
4 wins
DOV DOVER Corp
$210.37 +10.9% 1M +16.4% 1Y
Market cap
$28.20B
P/E
24.2x
Revenue (TTM)
$8.58B
Div. yield
–
Industrial Machinery Industrials

Head to Head

11 decided of 12

Power Solutions International leads on 7 of the 12 questions below (Power Solutions International 7, Ametek 4). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionPSIXAMEDOVLeader
Larger companyMarket capitalisation $1.03B $55.52B $28.20B AME
Cheaper on earningsLower P/E, profitable companies only 15.2x 35.2x 24.2x PSIX
Cheaper on forward earningsLower price / next fiscal year consensus EPS 15.6x 30.7x 20.6x PSIX
Faster revenue growthRevenue growth, trailing twelve months +13.2% +12.7% +8.2% PSIX
More profitableNet margin, trailing twelve months 10.0% 20.0% — AME
Better return on capitalReturn on invested capital 26.5% 12.8% — PSIX
Less leveragedLower net debt / EBITDA 0.0x 0.6x — PSIX
Higher dividend yieldTrailing dividend yield 0.00% 0.01% 0.00% –
Better 1-year returnPrice return, last 12 months -45.1% +36.7% +16.4% AME
Better 5-year returnAnnualised price return, 5 years +62.3%/yr +13.7%/yr +4.5%/yr PSIX
Less volatileAnnualised volatility, 1 year 109.6% 23.9% 24.9% AME
Higher overall scoreMean of the five percentile scores vs peers 75/100 63/100 42/100 PSIX

Percentile Scorecard

PSIXAMEDOV

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisPSIXAMEDOV
Valuation 81 #39 of 203 18 #166 of 203 46 #111 of 203
Growth 61 #74 of 188 64 #68 of 188 47 #101 of 188
Profitability 86 #26 of 183 94 #12 of 183 –
Financial Health 73 #59 of 216 69 #67 of 216 –
Shareholder Returns – 68 #49 of 152 33 #102 of 152
Overall 75 63 42
  • PSIX ranked among 222 companies in Machinery
  • AME ranked among 222 companies in Machinery
  • DOV ranked among 222 companies in Machinery

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodPSIXAMEDOVSPY
1 month +2.7%+0.4%+10.9% +0.7%
3 months +73.8%+4.9%+3.1% +3.7%
6 months -34.0%+6.9%-7.1% +7.1%
Year to date -15.3%+22.6%+7.7% +12.8%
1 year -45.1%+36.7%+16.4% +11.9%
3 years +1,597.5%+79.7%+63.8% +85.2%
3 years, per year +157.2%+21.6%+17.9% +22.8%
5 years +1,025.1%+90.1%+24.4% +67.6%
5 years, per year +62.3%+13.7%+4.5% +10.9%
10 years +413.0%+470.5%+284.3% +262.0%
10 years, per year +17.8%+19.0%+14.4% +13.7%

Risk

MeasurePSIXAMEDOVSPY
Volatility, 1Y 109.6%23.9%24.9% 12.7%
Downside volatility, 1Y 118.0%22.9%25.2% 12.6%
Beta vs S&P 500, 1Y 3.540.980.93 1.00
Return / volatility, 1Y -0.411.540.66 0.94
Max drawdown, 5Y -78.0%-27.3%-36.3% -25.4%
From 52-week high -51.0%-2.6%-9.8% -1.2%
52-week high $98.77$258.54$233.31 $779.14
52-week low $25.44$184.19$178.03 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultiplePSIXAMEDOV
P/E now vs peer median 16.4xmedian 25.8x 36.6xmedian 25.8x 24.3xmedian 25.8x
P/S now vs peer median 1.6xmedian 1.9x 7.3xmedian 1.9x 3.3xmedian 1.9x
EV/EBITDA now vs peer median 11.7xmedian 14.6x 24.1xmedian 14.6x —median 14.6x
P/FCF now vs peer median 16.6xmedian 22.2x 31.6xmedian 22.2x 21.7xmedian 22.2x
P/B now vs peer median 5.5xmedian 2.2x 5.1xmedian 2.2x —median 2.2x
PEG now vs peer median 0.37median 1.45 4.20median 1.45 4.26median 1.45

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsPSIXAMEDOV
Revenue $676.19M $7.86B $8.58B
Gross profit $161.31M $2.86B $3.40B
Operating income $87.91M $2.04B –
Net income $67.87M $1.58B –
Free cash flow $67.09M $1.82B –
R&D $19.16M – –
EPS (diluted) $2.94 $6.86 $8.60
Cash & equivalents $70.06M $495.45M –
Total debt $66.19M $2.04B –
Shares (diluted) 23.07M 229.86M 135.55M
Enterprise value $827.87M $53.65B $28.20B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricPSIXAMEDOV
P/E 16.4x 36.6x 24.3x
P/FCF 16.6x 31.6x 21.7x
P/Operating cash flow 15.0x 29.4x 20.1x
P/S 1.6x 7.3x 3.3x
P/B 5.5x 5.1x –
P/Tangible book 5.5x 8.2x –
EV/EBITDA 11.7x 24.1x –
EV/EBIT 12.6x 29.1x –
EV/Revenue 1.6x 7.5x 3.3x
EV/FCF 16.6x 32.5x –
EV/Operating cash flow 14.9x 30.2x 20.1x
PEG (3Y EPS CAGR) 0.37 4.20 4.26

Growth

14 metrics
MetricPSIXAMEDOV
Revenue growth (1Y) 13.2% 12.7% 8.2%
Revenue CAGR (3Y) 10.6% 7.0% 4.1%
Gross profit growth (1Y) -7.3% 13.4% 8.3%
Gross profit CAGR (3Y) 15.8% 7.9% 6.1%
Operating income growth (1Y) -14.4% 11.2% –
Operating income CAGR (3Y) 29.0% 8.2% –
Net income growth (1Y) -38.8% 9.6% –
Net income CAGR (3Y) 44.2% 8.5% –
EPS growth (1Y) -38.8% 10.4% -47.2%
EPS CAGR (3Y) 43.9% 8.7% 5.7%
Operating cash flow growth (1Y) 5.2% 8.1% 14.3%
Operating cash flow CAGR (3Y) 15.8% 11.0% 12.1%
Free cash flow growth (1Y) 7.8% 8.4% –
Free cash flow CAGR (3Y) 13.6% 12.0% –

Profitability

14 metrics
MetricPSIXAMEDOV
Gross margin 23.9% 36.4% –
EBITDA margin 14.0% 31.2% –
Operating margin 13.0% 25.9% –
Pretax margin 12.1% 24.3% –
Net margin 10.0% 20.0% –
FCF margin 9.9% 23.2% –
Operating cash flow margin 11.0% 24.9% 16.4%
Return on equity 34.9% 14.2% –
Return on assets 15.4% 9.6% –
Return on invested capital 26.5% 12.8% –
Return on capital employed 27.1% 14.8% –
Asset turnover 1.5x 0.5x –
Cash conversion (OCF / net income) 1.1x 1.2x –
Stock comp / revenue 0.1% 0.6% –

Financial Health

11 metrics
MetricPSIXAMEDOV
Debt / assets 14.6% 12.3% –
Debt / equity 0.3x 0.2x –
Net debt / EBITDA 0.0x 0.6x –
Debt / FCF 1.0x 1.1x –
Liabilities / assets 55.2% 32.1% –
Equity / assets 44.8% 67.9% –
Interest coverage 13.4x 21.1x –
Current ratio 2.6x 1.2x –
Quick ratio 1.4x 0.6x –
Cash ratio 0.6x 0.2x –
Altman Z-score 5.44 8.50 –

Shareholder Returns

7 metrics
MetricPSIXAMEDOV
Dividend yield – 0.5% 1.0%
Net buyback yield – 0.7% –
Shareholder yield – 1.2% 1.0%
Payout ratio (earnings) – 18.9% –
Payout ratio (FCF) – 16.3% –
Dividend growth (1Y) – 9.4% –
Dividend CAGR (3Y) – 11.3% –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusPSIXAMEDOV
Forward P/E 15.6xFY2026 30.7xFY2026 20.6xFY2026
EPS, next fiscal year $3.11FY2026 $8.20FY2026 $10.22FY2026
EPS growth, next FY -37.6%FY2026 +10.4%FY2026 +6.3%FY2026
EPS growth, the year after +22.5% +8.4% +11.4%
Revenue, next fiscal year $656.20MFY2026 $7.96BFY2026 $8.16BFY2026
Revenue growth, next FY -9.2%FY2026 +7.5%FY2026 +0.8%FY2026
Revenue growth, the year after +31.5% +18.3% +17.8%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersPSIXAMEDOV
Held by institutions 36.4% 89.6% 91.1%
Institutions holding 159 1,196 1,164
Change in shares held, QoQ +24.1% +2.3% -0.3%
Institutions buying 92 615 500
Institutions selling 45 399 406
Buyers to sellers 2.04 1.54 1.23

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

PSIXAMEDOV
PSIX 1.00 0.36 0.26
AME 0.36 1.00 0.65
DOV 0.26 0.65 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, PSIX, AME and DOV?

Ametek (AME) is the largest by market capitalisation: Power Solutions International (PSIX) $1.03B, Ametek (AME) $55.52B, Dover (DOV) $28.20B.

Which stock is cheaper, PSIX, AME and DOV?

Power Solutions International (PSIX) trades on the lowest price-to-earnings ratio (Power Solutions International (PSIX) 15.2x, Ametek (AME) 35.2x, Dover (DOV) 24.2x). On next year's consensus earnings, Power Solutions International (PSIX) is cheapest (Power Solutions International (PSIX) 15.6x, Ametek (AME) 30.7x, Dover (DOV) 20.6x). A lower multiple can reflect slower expected growth, so read it next to the growth figures.

Which company is growing faster?

Power Solutions International (PSIX) grew revenue fastest over the trailing twelve months: Power Solutions International (PSIX) +13.2%, Ametek (AME) +12.7%, Dover (DOV) +8.2%.

Which company is more profitable?

Ametek (AME) has the highest net margin (Power Solutions International (PSIX) 10.0%, Ametek (AME) 20.0%). On return on invested capital, Power Solutions International (PSIX) leads (Power Solutions International (PSIX) 26.5%, Ametek (AME) 12.8%).

Which stock has performed better?

Over the past year Ametek (AME) returned the most: Power Solutions International (PSIX) -45.1%, Ametek (AME) +36.7%, Dover (DOV) +16.4%. Over five years, Power Solutions International (PSIX) compounded fastest (Power Solutions International (PSIX) +62.3%/yr, Ametek (AME) +13.7%/yr, Dover (DOV) +4.5%/yr). Returns are price only, before dividends.

Which pays a higher dividend?

Only one of these companies pays a dividend: Power Solutions International (PSIX) 0.00%, Ametek (AME) 0.01%, Dover (DOV) 0.00%. Power Solutions International (PSIX) and Dover (DOV) pays no regular dividend.

Which stock is riskier?

By one-year price volatility, Ametek (AME) has been the steadiest (Power Solutions International (PSIX) 109.6%, Ametek (AME) 23.9%, Dover (DOV) 24.9%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, PSIX, AME and DOV?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Power Solutions International (PSIX) leads on 7. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.